Neurocrine Biosciences Statistics
Total Valuation
LON:0K6R has a market cap or net worth of GBP 9.65 billion. The enterprise value is 9.29 billion.
Market Cap | 9.65B |
Enterprise Value | 9.29B |
Important Dates
The last earnings date was Thursday, July 31, 2025.
Earnings Date | Jul 31, 2025 |
Ex-Dividend Date | n/a |
Share Statistics
Current Share Class | 99.18M |
Shares Outstanding | n/a |
Shares Change (YoY) | -0.05% |
Shares Change (QoQ) | -1.46% |
Owned by Insiders (%) | n/a |
Owned by Institutions (%) | n/a |
Float | 98.00M |
Valuation Ratios
The trailing PE ratio is 37.97 and the forward PE ratio is 14.58.
PE Ratio | 37.97 |
Forward PE | 14.58 |
PS Ratio | 5.27 |
PB Ratio | 4.91 |
P/TBV Ratio | 4.98 |
P/FCF Ratio | n/a |
P/OCF Ratio | n/a |
PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 21.11, with an EV/FCF ratio of 24.06.
EV / Earnings | 36.52 |
EV / Sales | 4.90 |
EV / EBITDA | 21.11 |
EV / EBIT | 24.64 |
EV / FCF | 24.06 |
Financial Position
The company has a current ratio of 3.20, with a Debt / Equity ratio of 0.18.
Current Ratio | 3.20 |
Quick Ratio | 2.88 |
Debt / Equity | 0.18 |
Debt / EBITDA | 0.84 |
Debt / FCF | 0.93 |
Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is 13.39% and return on invested capital (ROIC) is 10.42%.
Return on Equity (ROE) | 13.39% |
Return on Assets (ROA) | 8.67% |
Return on Invested Capital (ROIC) | 10.42% |
Return on Capital Employed (ROCE) | 14.93% |
Revenue Per Employee | 1.02M |
Profits Per Employee | 141,236 |
Employee Count | 1,800 |
Asset Turnover | 0.70 |
Inventory Turnover | 18.63 |
Taxes
In the past 12 months, LON:0K6R has paid 130.51 million in taxes.
Income Tax | 130.51M |
Effective Tax Rate | 33.92% |
Stock Price Statistics
The stock price has decreased by -11.15% in the last 52 weeks.
Beta (5Y) | n/a |
52-Week Price Change | -11.15% |
50-Day Moving Average | 128.12 |
200-Day Moving Average | 123.42 |
Relative Strength Index (RSI) | 41.69 |
Average Volume (20 Days) | 168 |
Short Selling Information
Short Interest | n/a |
Short Previous Month | n/a |
Short % of Shares Out | n/a |
Short % of Float | n/a |
Short Ratio (days to cover) | 2.87 |
Income Statement
In the last 12 months, LON:0K6R had revenue of GBP 1.83 billion and earned 254.22 million in profits. Earnings per share was 2.48.
Revenue | 1.83B |
Gross Profit | 1.16B |
Operating Income | 364.29M |
Pretax Income | 384.73M |
Net Income | 254.22M |
EBITDA | 385.10M |
EBIT | 364.29M |
Earnings Per Share (EPS) | 2.48 |
Balance Sheet
The company has 712.09 million in cash and 357.51 million in debt, giving a net cash position of 354.59 million.
Cash & Cash Equivalents | 712.09M |
Total Debt | 357.51M |
Net Cash | 354.59M |
Net Cash Per Share | n/a |
Equity (Book Value) | 1.97B |
Book Value Per Share | 19.86 |
Working Capital | 877.78M |
Cash Flow
In the last 12 months, operating cash flow was 414.07 million and capital expenditures -28.17 million, giving a free cash flow of 385.90 million.
Operating Cash Flow | 414.07M |
Capital Expenditures | -28.17M |
Free Cash Flow | 385.90M |
FCF Per Share | n/a |
Margins
Gross margin is 63.11%, with operating and profit margins of 19.89% and 13.88%.
Gross Margin | 63.11% |
Operating Margin | 19.89% |
Pretax Margin | 21.00% |
Profit Margin | 13.88% |
EBITDA Margin | 21.02% |
EBIT Margin | 19.89% |
FCF Margin | 21.06% |
Dividends & Yields
LON:0K6R does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | n/a |
Buyback Yield | 0.05% |
Shareholder Yield | n/a |
Earnings Yield | 2.63% |
FCF Yield | 4.00% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
Lynch Fair Value | |
Lynch Upside | |
Graham Number | |
Graham Upside |
Stock Splits
This stock does not have any record of stock splits.
Last Split Date | n/a |
Split Type | n/a |
Split Ratio | n/a |
Scores
LON:0K6R has an Altman Z-Score of 7.8 and a Piotroski F-Score of 4.
Altman Z-Score | 7.8 |
Piotroski F-Score | 4 |